Posts

covid

What Experts Want You To Know About The New Covid-19 Vaccine As Cases Continue To Surge In The US

As Covid-19 continues its summer surge throughout the United States, new vaccines have been made available for individuals looking to get another level of protection as we enter autumn and the back-to-school season; when cases in the past few years have been known to surge. 

According to the US Centers for Disease Control and Prevention, there are “high to very high” levels of Covid-19 in the wastewater in nearly every state, reported Politico. A recent report from the Pandemic Mitigation Collaborative estimated that about 2.5% of the US population is currently infected with Covid. 

Embed from Getty Images

Even with this increase in infections, the US population hasn’t been keeping up with their Covid-19 vaccinations to protect themselves from getting sick and spreading the virus further. 

“One of the challenges of today is just that people aren’t going to get vaccinated. Most people are confused. They don’t really understand what’s happening or what the risk to them is when it comes to Covid,” said Michael Osterholm, an epidemiologist and director of the University of Minnesota’s Center for Infectious Disease Research and Policy. 

Politico reported on a recent poll from the Annenberg Public Policy Center that revealed more than 20% of Americans think it’s safer to get sick from Covid-19 than to get a vaccine. This percentage has increased by 10% within the past three years. 

The CDC revealed that last year, 22.5% of adults and 14.4% of children received an updated Covid-19 vaccine. The risk of hospitalization and death is not close to what it was back in 2021, however, that doesn’t mean that the public shouldn’t still view the virus as a threat. Immunocompromised individuals and the elderly are still those at the most risk should they be infected. 

Embed from Getty Images

In June, the FDA and vaccine manufacturers worked to incorporate the KP.2 Covid strain into vaccine formulas, as that particular variant was the most prevalent in the beginning of the summer. 

However, the KP.3 and KP.3.1.1 subvariants of KP.2 are currently the most prevalent strains of Covid, and account for more than half of the cases in the US, said the CDC. 

Public health experts are still urging the population to get their updated vaccines due to the consistent surges of cases, as getting vaccinated before you’re exposed or infected is your best chance at avoiding the virus or having a less severe reaction to becoming infected. 

In fact, a CDC study showed that last year’s vaccine provided 54% protection against symptomatic Covid-19 infections. 

If an individual was recently sick with Covid, however, the CDC recommends waiting to get an updated dose until three months after the symptoms first appeared or from when they received their first positive test.

Crystal La Tour Rambaund manages the vaccine program at the Pima County Health Department in Arizona, and stated that the US is experiencing a “Covid fatigue,” meaning citizens aren’t as concerned about the virus and its spreading, despite the surges. 

“The population we are concerned about are the people on the fence. They are not completely anti-[vaccine], and they are not completely all about it. And for those groups of people, it’s a very small thing that could tip the scale in the direction of not being vaccinated,” she said. 

moderna

UK Approves Updated Covid-19 Vaccine From Moderna, Targets Omicron And Original Strain 

The United Kingdom has become the first nation to approve an updated version of Moderna’s Covid-19 vaccine booster, meant to target the omicron strain as well as the original virus that first appeared in 2020. 

“An updated version of the COVID-19 vaccine made by Moderna that targets two coronavirus variants (known as a “bivalent” vaccine) has today been approved for adult booster doses by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness,” read an official government release.

Embed from Getty Images

“Half of the booster, called Spikevax bivalent Original/Omicron, targets the original coronavirus strain while the other half targets Omicron,” it said.

The MHRA, the UK government’s independent expert scientific advisory board, endorsed the decision to approve of the new vaccine after carefully reviewing the evidence. 

The clinical trial by Moderna reported that the booster targets Omicron and showed a stronger immune response against the variant in addition to the original strain. The company said the “updated booster showed a potent response against BA.4 and BA. 5 sub variants.” 

“The side effects are the same as for the original Moderna booster dose and found to be typically mild and self-resolving. No serious safety concerns were identified,” the UK government release said.

Embed from Getty Images

MHRA Chief Executive Dr. June Raine said that “the new Moderna booster will help keep communities protected.

“The first generation of COVID-19 vaccines being used in the UK continue to provide important protection against the disease and save lives. What this bivalent vaccine gives us is a sharpened tool in our armory to help protect us against this disease as the virus continues to evolve.”

The UK’s Joint Committee on Vaccination and Immunization will advise on the vaccine’s rollout, as it is not yet clear who will be offered the booster or when. 

Stéphane Bancel, Chief Executive Officer of Moderna, said on Twitter he was “delighted the vaccine had been approved.”

“This represents the first authorization of an Omicron-containing bivalent vaccine, this bivalent vaccine has an important role to play in protecting people in the UK from Covid-19 as we enter the winter months.”

Besides Moderna, Pfizer and BioNTech have been testing two Covid-19 vaccine boosters that will also target the Omicron variant.